WITH its business in limbo, Indofarma is now waiting for a savior. After being hit by financial problems, from business losses to allegations of misconduct, Indofarma finds itself chased to resolve many obligations. Indofarma Chief Executive Officer (CEO), Yeliandriani, told Tempo on Tuesday, May 28, that the company is facing a case of postponement of debt payment obligations or PKPU filed by creditors. “Currently we are focused on re